Functional and phenotypical impairment of polymorphonuclear cells in atopic dermatitis: An additional cause for the known susceptibility to infections?

Dermatology

Volumn 224, Issue 4, 2012, Pages 323-330

  Fierro, Maria Teresa ^a   Banche, Giuliana ^a   Marenco, Federica ^a   Novelli, Mauro ^a   Allizond, Valeria ^a   Mandras, Narcisa ^a   Murabito, Pierangela ^a   Merlino, Chiara ^a   Quaglino, Pietro ^a   Bernengo, Maria Grazia ^a   Cuffini, Anna Maria ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Atopic dermatitis; Human polymorphonuclear granulocytes; Infections; Intracellular killing; Phagocytosis; Toll like receptors

Indexed keywords

ANTIGEN; CD11B ANTIGEN; CD66B ANTIGEN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATOPIC DERMATITIS; BACTERICIDAL ACTIVITY; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; INNATE IMMUNITY; KLEBSIELLA PNEUMONIAE; LEUKOCYTE FUNCTION; MALE; PHAGOCYTOSIS; PHENOTYPE; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL;

ADULT; COHORT STUDIES; DERMATITIS, ATOPIC; DISEASE SUSCEPTIBILITY; FEMALE; FLOW CYTOMETRY; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; NEUTROPHILS; PHAGOCYTES; PHAGOCYTOSIS; PHENOTYPE; TOLL-LIKE RECEPTORS; YOUNG ADULT;

EID: 84864880647     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000339180     Document Type: Article

References (39)

1. Ker J, Hartert TV: The atopic march: what's the evidence? Ann Allergy Asthma Immunol 2009; 103:282-289.
2. Johansson SG, Bieber T, Dahl R, Fried-mann PS, Lanier BQ, Lockey RF, Motala C, OrtegAmartell JA, Platts-Mills TA, Ring J, Thien F, Van Cauwenberge P, Williams HC: Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization. J Allergy Clin Immunol 2004; 113: 832-836.
3. Schittek B: The antimicrobial skin barrier in patients with atopic dermatitis. Curr Probl Dermatol 2011; 41:54-67.
4. Lebre MC, van Capel TM, Bos JD, Knol EF, Kapsenberg ML, de Jong EC: Aberrant function of peripheral blood myeloid and plasma-cytoid dendritic cells in atopic dermatitis patients. J Allergy Clin Immunol 2008; 122: 969-976.
5. Boguniewicz M, Leung DY: Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 2011; 242: 233-246.
6. Akdis M, Trautmann A, Klunker S, Daigle I, Kucuksezer UC, Deglmann W, Disch R, Bla-ser K, Akdis CA: Thelper (Th) 2 predomi-nance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells. FASEB J 2003; 17:1026-1035.
7. De Benedetto A, Agnihothri R, McGirt LY, Bankova LG, Beck LA: Atopic dermatitis: a disease caused by innate immune defects? J Invest Dermatol 2009; 129:14-30.
8. Leung DY, Jain N, Leo HL: New concepts in the pathogenesis of atopic dermatitis. Curr Opin Immunol 2003; 15:634-638.
9. Greenberg S, Grinstein S: Phagocytosis and innate immunity. Curr Opin Immunol 2002; 14: 136-145.
10. Rogge JL, Hanifin JM: Immunodeficiencies in severe atopic dermatitis. Depressed che-motaxis and lymphocyte transformation. Arch Dermatol 1976; 112: 1391-1394.
11. Ternowitz T, Herlin T: Defective monocyte and polymorphonuclear leukocyte chemo-taxis and clinical characteristics in atopic dermatitis. Arch Dermatol Res 1986; 278: 454-459.
12. Forte WC, Guardian VC, Mantovani PA, Dionigi PC, Menezes MC: Evaluation of phagocytes in atopic dermatitis. Allergol Im-munopat hol 2009; 37: 302-308.
13. Mrowietz U, Konter U, Traut R, Schroder JM, Christophers E: Atopic dermatitis: inf lu-ence of bacterial infections on human mono-cyte and neutrophil granulocyte functional act ivities. J Allergy Clin Immunol 1988; 82: 1027-1036.
14. Ozinsky A, Underhill DM, Fontenot JD, Haj-jar AM, Smith KD, Wilson CB, Schroeder L, Aderem A: The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 2000; 97:13766-13771.
15. Sabroe I, Dower SK, Whyte MK: The role of Toll-like receptors in the regulation of neu-trophil migration, activation, and apoptosis. Clin Infect Dis 2005; 41:S421-S426.
16. Fierro MT, Cuffini AM, Novelli M, Banche G, Allizond V, Comessatti A, Brizio M, Sca-las D, Merlino C, Quaglino P, Bernengo MG: Functional and phenotypical alterations of polymorphonuclear cells in Sézary syndrome patients. Eur J Dermatol 2011; 21:921-929.
17. Banche G, Tullio V, Allizond V, Mandras N, Roana J, Scalas D, El Fassi F, D'Antico S, Cuffini AM, Carlone N: Synergistic effect of erythromycin on PMN antibacterial activity against erythromycin-resistant phenotypes of Streptococcus pyogenes. Int J Antimicrob Agents 2010; 36:319-323.
18. Tullio V, Cuffini AM, Banche G, Mandras N, Allizond V, Roana J, Giacchino F, Bonello F, Ungheri D, Carlone NA: Role of fosfomycin tromethamine in modulating non-specific defence mechanisms in chronic uremic patients towards ESBL-producing Escherichia coli. Int J Immunopathol Pharmacol 2008; 21: 153-160.
19. Scalas D, Banche G, Merlino C, Giacchino F, Allizond V, Garneri G, Patti R, Roana J, Mandras N, Tullio V, Cuffini AM: Caspo-fungin role in restoring the impaired phagocyte-dependent innate immunity in chronic haemodialysis patients towards Candida al-bicans. Int J Antimicrob Agents 2012; 39:73-76.
20. Robinson JM: Phagocytic leukocytes and reactive oxygen species. Histochem Cell Biol 2009; 131: 465-469.
21. Christopher E, Henseler T: Contrasting disease patterns in psoriasis and atopic dermatitis. Arch Dermatol Res 1987; 279:S 48.
22. Schäfer L, Kragballe K, Jepsen LV, Iversen L: Reduced neutrophil LTB4 release in atopic dermatitis patients despite normal fatty acid composition. Invest Dermatol 1991; 96:16-19.
23. Peller S, Kaufman S, Yona R: Functions of polymorphonuclear (PMN) leukocytes of patients with lymphoproliferative diseases. Immunol Lett 1985; 10: 53-56.
24. Itälä M, Vainio O, Remes K: Functional abnormalities in granulocytes predict susceptibility to bacterial infections in chronic lymphocytic leukaemia. Eur J Haematol 1996; 57: 46-53.
25. Goddard DS, Yamanaka K, Kupper TS, Jones DA: Activation of neutrophils in cutaneous T-cell lymphoma. Clin Cancer Res 2005; 11: 8243-8249.
26. Power C, Wang JH, Sookhai S, Wu QD, Redmond HP: Proinflammatory effects of bacterial lipoprotein on human neutrophil activation status, function and cytotoxic potential in vitro. Shock 2001; 15: 461-466.
27. Yamada H, Kurashimo S, Chihara J, MatsukurAm, Yudate T, Tezuka T: Overexpression of CD11b on eosinophils in atopic dermatitis: downregulation by cyclosporin A and upreg-ulation by interleukin 5. Int Arch Allergy Immunol 1999; 120(suppl 1):100-103.
28. Bryan SA, Jose PJ, Topping JR, Wilhelm R, Soderberg C, Kertesz D, Barnes PJ, Williams TJ, Hansel TT, Sabroe I: Responses of leukocytes to chemokines in whole blood and their antagonism by novel CC-chemokine receptor 3 antagonists. Am J Respir Crit Care Med 2002; 165:1602-1609.
29. Lundahl J, Jacobson SH, Paulsson JM: IL-8 from local subcutaneous wounds regulates CD11b activation. Scand J Immunol 2012; 75: 419-425.
30. NakagawAm, Bondy GP, Waisman D, Min-shall D, Hogg JC, van Eeden SF: The effect of glucocorticoids on the expression of L-selec-tin on polymorphonuclear leukocyte. Blood 1999; 93: 2730-2737.
31. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF: A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA 1998; 95: 588-593.
32. Lien E, Ingalls RR: Toll-like receptors. Crit Care Med 2002; 30(suppl):S1-S11.
33. Kopp E, Medzhitov R: Recognition of micro-bial infection by Toll-like receptors. Curr Opin Immunol 2003; 15: 396-401.
34. Carpenter S, O'Neill LA: How important are Toll-like receptors for antimicrobial responses? Cell Microbiol 2007; 9: 1891-1901.
35. Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA: A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000; 68:6398-6401.
36. Ahmad-Nejad P, Mrabet-Dahbi S, Breuer K, Klotz M, Werfel T, Herz U, Heeg K, Neu-maier M, Renz H: The toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J Allergy Clin Immunol 2004; 113: 565-567.
37. Weidinger S, Novak N, Klopp N, Baurecht H, Wagenpfeil S, Rummler L, Ring J, Behrendt H, Illig T: Lack of association between Tolllike receptor 2 and Toll-like receptor 4 polymorphisms and atopic eczema. J Allergy Clin Immunol 2006; 118:277-279.
38. Mrabet-Dahbi S, Dalpke AH, Niebuhr M, Frey M, Draing C, Brand S Heeg K, Werfel T, Renz H: The Toll-like receptor 2 R753Q mutation modifies cytokine production and Toll-like receptor expression in atopic dermatitis. J Allergy Clin Immunol 2008; 121: 1013-1019.
39. Sümegi A, Szegedi A, Gál M, et al: Analysis of components of the CD14/TLR system on leukocytes of patients with atopic dermatitis. Int Arch Allergy Immunol 2007; 143:177-184.